Quarterly Report (10-q)

0000101538false--12-31Q32021000003274837315000000075949757106117844100000000.010.010.010.010.010.010.011000000010000000100000001000000010000000100000001000000010000000075000017790417510050075000075000017790417790417510051751005978473731002204550.38940.28525621520020000.8576500000.85102079900001015382021-01-012021-09-300000101538uamy:PayCheckProtectionProgramMember2020-04-012020-04-200000101538uamy:ZeoliteMember2020-01-012020-09-300000101538uamy:PreciousMetalsMember2020-01-012020-09-300000101538uamy:SubtotalAntimonyMember2020-07-012020-09-300000101538uamy:SubtotalAntimonyMember2020-01-012020-09-300000101538uamy:MexicoAntimonyMember2020-07-012020-09-300000101538uamy:SubtotalAntimonyMember2021-01-012021-09-300000101538uamy:MexicoAntimonyMember2020-01-012020-09-300000101538uamy:MexicoAntimonyMember2021-01-012021-09-300000101538uamy:SubtotalAntimonyMember2021-07-012021-09-300000101538uamy:MexicoAntimonyMember2021-07-012021-09-300000101538uamy:UnitedStatesAntimonyMember2020-07-012020-09-300000101538uamy:UnitedStatesAntimonyMember2020-01-012020-09-300000101538uamy:UnitedStatesAntimonyMember2021-01-012021-09-300000101538uamy:UnitedStatesAntimonyMember2021-07-012021-09-300000101538uamy:SubtotalAntimonyMember2020-12-310000101538uamy:MexicoAntimonyMember2020-12-310000101538uamy:PreciousMetalsMember2020-12-310000101538uamy:UnitedStatesAntimonyMember2020-12-310000101538uamy:PreciousMetalsMember2021-09-300000101538uamy:SubtotalAntimonyMember2021-09-300000101538uamy:MexicoAntimonyMember2021-09-300000101538uamy:UnitedStatesAntimonyMember2021-09-300000101538uamy:ConcentrateProcessingAgreementMemberuamy:HillgroveMinesLtdMember2021-01-012021-09-300000101538uamy:ConcentrateProcessingAgreementMemberuamy:HillgroveMinesLtdMember2021-04-012021-04-300000101538uamy:ConcentrateProcessingAgreementMemberuamy:HillgroveMinesLtdMember2021-04-012021-06-300000101538uamy:ConcentrateProcessingAgreementMemberuamy:HillgroveMinesLtdMember2020-12-3100001015382021-01-012021-03-310000101538uamy:TwentyNineteenMember2021-01-012021-09-300000101538uamy:TwentyFifteenMember2021-01-012021-09-300000101538uamy:Warrant2Member2021-06-300000101538uamy:Warrant1Member2021-06-300000101538uamy:Warrant1Member2021-02-030000101538uamy:Warrant1Member2021-02-012021-02-030000101538uamy:FebruaryTwentyTwentyOneMember2021-02-012021-02-180000101538uamy:FebruaryTwentyTwentyOneMember2021-02-012021-02-030000101538uamy:FebruaryTwentyTwentyOneMember2021-02-030000101538uamy:FebruaryTwentyTwentyOneMember2021-06-300000101538uamy:FebruaryTwentyTwentyOneMember2021-01-012021-09-300000101538uamy:FebruaryTwentyTwentyOneMember2021-02-180000101538uamy:Warrant2Member2021-01-012021-09-300000101538uamy:Warrant1Member2021-01-012021-09-300000101538uamy:Warrant3Member2021-01-012021-09-300000101538uamy:Warrant4Member2021-01-012021-09-300000101538srt:MaximumMember2021-09-300000101538srt:MaximumMember2021-01-012021-09-300000101538srt:MaximumMember2019-12-310000101538srt:MaximumMember2020-12-310000101538srt:MinimumMember2021-09-300000101538srt:MinimumMember2021-01-012021-09-300000101538srt:MinimumMember2019-12-310000101538srt:MinimumMember2020-12-310000101538uamy:MrLawrenceMember2021-01-012021-09-300000101538uamy:MrLawrenceMember2021-09-300000101538srt:ChiefExecutiveOfficerMember2020-12-310000101538srt:ChiefExecutiveOfficerMember2021-01-012021-12-310000101538srt:PresidentMember2021-09-300000101538srt:PresidentMember2021-01-012021-12-310000101538srt:PresidentMember2020-12-310000101538srt:ChiefExecutiveOfficerMember2021-09-300000101538srt:ChiefExecutiveOfficerMember2021-01-012021-09-300000101538srt:PresidentMember2021-01-012021-09-300000101538uamy:PhyllisRiceMember2021-09-300000101538uamy:PhyllisRiceMember2020-12-310000101538uamy:CatFinancialServicesMember2020-12-310000101538uamy:CatFinancialServicesMember2021-09-300000101538uamy:ZeoMember2020-12-310000101538uamy:ZeoMember2021-09-300000101538uamy:PromissoryNotePayable2Member2020-12-310000101538uamy:PromissoryNotePayable1Member2020-12-310000101538uamy:PromissoryNotePayable2Member2021-09-300000101538uamy:PromissoryNotePayable1Member2021-09-300000101538uamy:ZeoliteMember2020-12-310000101538uamy:ZeoliteMember2021-09-300000101538uamy:AntimonyMember2020-12-310000101538uamy:AntimonyMember2021-09-300000101538uamy:AntimonyOreMember2020-12-310000101538uamy:AntimonyOreMember2021-09-300000101538uamy:AntimonyOxideMember2020-12-310000101538uamy:AntimonyOxideMember2021-09-300000101538uamy:AntimonyMetalMember2020-12-310000101538uamy:AntimonyMetalMember2021-09-300000101538uamy:CompanyFMember2021-09-3000001015382020-01-012020-12-310000101538uamy:CompanyFMember2020-12-310000101538uamy:CompanyJMember2020-12-310000101538uamy:CompanyJMember2021-09-300000101538uamy:CompanyIMember2020-12-310000101538uamy:CompanyIMember2021-09-300000101538uamy:CompanyGMember2020-12-310000101538uamy:CompanyGMember2021-09-300000101538uamy:CompanyHMember2020-12-310000101538uamy:CompanyHMember2021-09-300000101538uamy:CompanyBMember2020-01-012020-12-310000101538uamy:CompanyBMember2020-12-310000101538uamy:CompanyBMember2021-09-300000101538uamy:CompanyCMember2020-01-012020-09-300000101538uamy:CompanyDMember2020-07-012020-09-300000101538uamy:CompanyEMember2020-01-012020-09-300000101538uamy:CompanyCMember2020-07-012020-09-300000101538uamy:CompanyDMember2021-07-012021-09-300000101538uamy:CompanyEMember2020-07-012020-09-300000101538uamy:CompanyCMember2021-07-012021-09-300000101538uamy:CompanyDMember2020-01-012020-09-300000101538uamy:CompanyEMember2021-01-012021-09-300000101538uamy:CompanyDMember2021-01-012021-09-300000101538uamy:CompanyCMember2021-01-012021-09-300000101538uamy:CompanyEMember2021-07-012021-09-300000101538uamy:CompanyBMember2020-01-012020-09-300000101538uamy:CompanyBMember2020-07-012020-09-300000101538uamy:CompanyBMember2021-07-012021-09-300000101538uamy:CompanyBMember2021-01-012021-09-300000101538uamy:CompanyAMember2020-01-012020-09-300000101538uamy:CompanyAMember2020-07-012020-09-300000101538uamy:CompanyAMember2021-07-012021-09-300000101538uamy:CompanyAMember2021-01-012021-09-300000101538uamy:CanadaMember2020-01-012020-09-300000101538uamy:CanadaMember2020-07-012020-09-300000101538uamy:CanadaMember2021-07-012021-09-300000101538uamy:CanadaMember2021-01-012021-09-300000101538uamy:UnitedStatesMember2020-01-012020-09-300000101538uamy:UnitedStatesMember2020-07-012020-09-300000101538uamy:UnitedStatesMember2021-07-012021-09-300000101538uamy:UnitedStatesMember2021-01-012021-09-300000101538uamy:PreciousMetalsMember2020-01-012020-09-230000101538uamy:PreciousMetalsMember2020-07-012020-09-300000101538uamy:PreciousMetalsMember2021-07-012021-09-300000101538uamy:PreciousMetalsMember2021-01-012021-09-300000101538uamy:ZeoliteMember2020-01-012020-09-230000101538uamy:ZeoliteMember2020-07-012020-09-300000101538uamy:ZeoliteMember2021-07-012021-09-300000101538uamy:ZeoliteMember2021-01-012021-09-3000001015382020-01-012020-09-230000101538uamy:AntimonyMember2020-01-012020-09-230000101538uamy:AntimonyMember2020-07-012020-09-300000101538uamy:AntimonyMember2021-07-012021-09-300000101538uamy:AntimonyMember2021-01-012021-09-300000101538uamy:WarrantsMember2020-01-012020-09-300000101538uamy:WarrantsMember2021-01-012021-09-300000101538us-gaap:CumulativePreferredStockMember2021-01-012021-09-300000101538us-gaap:CumulativePreferredStockMember2020-01-012020-09-300000101538us-gaap:RetainedEarningsMember2021-07-012021-09-300000101538us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300000101538us-gaap:CommonStockMember2021-07-012021-09-300000101538us-gaap:PreferredStockMember2021-07-012021-09-3000001015382021-06-300000101538us-gaap:RetainedEarningsMember2021-06-300000101538us-gaap:AdditionalPaidInCapitalMember2021-06-300000101538us-gaap:CommonStockMember2021-06-300000101538us-gaap:PreferredStockMember2021-06-300000101538us-gaap:RetainedEarningsMember2021-09-300000101538us-gaap:AdditionalPaidInCapitalMember2021-09-300000101538us-gaap:CommonStockMember2021-09-300000101538us-gaap:PreferredStockMember2021-09-300000101538us-gaap:PreferredStockMember2021-01-012021-09-300000101538us-gaap:RetainedEarningsMember2021-01-012021-09-300000101538us-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-300000101538us-gaap:CommonStockMember2021-01-012021-09-300000101538us-gaap:RetainedEarningsMember2020-12-310000101538us-gaap:AdditionalPaidInCapitalMember2020-12-310000101538us-gaap:CommonStockMember2020-12-310000101538us-gaap:PreferredStockMember2020-12-310000101538us-gaap:RetainedEarningsMember2020-07-012020-09-300000101538us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300000101538us-gaap:CommonStockMember2020-07-012020-09-300000101538us-gaap:PreferredStockMember2020-07-012020-09-3000001015382020-06-300000101538us-gaap:RetainedEarningsMember2020-06-300000101538us-gaap:AdditionalPaidInCapitalMember2020-06-300000101538us-gaap:CommonStockMember2020-06-300000101538us-gaap:PreferredStockMember2020-06-3000001015382020-09-300000101538us-gaap:RetainedEarningsMember2020-09-300000101538us-gaap:AdditionalPaidInCapitalMember2020-09-300000101538us-gaap:CommonStockMember2020-09-300000101538us-gaap:PreferredStockMember2020-09-300000101538us-gaap:RetainedEarningsMember2020-01-012020-09-300000101538us-gaap:AdditionalPaidInCapitalMember2020-01-012020-09-300000101538us-gaap:CommonStockMember2020-01-012020-09-300000101538us-gaap:PreferredStockMember2020-01-012020-09-3000001015382019-12-310000101538us-gaap:RetainedEarningsMember2019-12-310000101538us-gaap:AdditionalPaidInCapitalMember2019-12-310000101538us-gaap:CommonStockMember2019-12-310000101538us-gaap:PreferredStockMember2019-12-3100001015382020-01-012020-09-3000001015382020-07-012020-09-3000001015382021-07-012021-09-300000101538us-gaap:SeriesDPreferredStockMember2020-12-310000101538us-gaap:SeriesDPreferredStockMember2021-09-300000101538us-gaap:SeriesCPreferredStockMember2020-12-310000101538us-gaap:SeriesCPreferredStockMember2021-09-300000101538us-gaap:SeriesBPreferredStockMember2020-12-310000101538us-gaap:SeriesBPreferredStockMember2021-09-300000101538us-gaap:SeriesAPreferredStockMember2020-12-310000101538us-gaap:SeriesAPreferredStockMember2021-09-3000001015382020-12-3100001015382021-09-3000001015382021-11-15iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)
☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended September 30, 2021

	OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the transition period from to

Commission File No. 001-08675

UNITED STATES ANTIMONY CORPORATION

(Exact name of Registrant as specified in its charter)

Montana

81-0305822

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

P.O. Box 643, Thompson Falls, Montana

(Address of principal executive offices)

Registrant’s telephone number: (406 )827-3523

Securities registered pursuant to Section 12(g) of the Act:

Title of Each Class		Trading Symbol(s)		Name of Each Exchange on Which Registered
Common Stock, $0.01 par value		UAMY		NYSE American

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large Accelerated Filer	☐	Accelerated Filer	☐
Non-Accelerated Filer	☒	Small Reporting Company	☒
		Emerging Growth Company	☐

Indicated by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):Yes ☐ No ☒

APPLICABLE ONLY TO CORPORATE ISSUERS:

At November 15, 2021, the registrant had outstanding 106,117,844 shares of par value $0.01 common stock.

UNITED STATES ANTIMONY CORPORATION

QUARTERLY REPORT ON FORM 10-Q

FOR THE PERIOD

ENDED SEPTEMBER 30, 2021

TABLE OF CONTENTS

		Page

PART I – FINANCIAL INFORMATION

Item 1: Financial Statements (unaudited)		1-18

Item 2: Management’s Discussion and Analysis of Results of Operations and Financial Condition		19-23

Item 3: Quantitative and Qualitative Disclosure about Market Risk		24

Item 4: Controls and Procedures		24

PART II – OTHER INFORMATION

Item 1: Legal Proceedings		26

Item 2: Unregistered Sales of Equity Securities and Use of Proceeds		26

Item 3: Defaults upon Senior Securities		26

Item 4: Mine Safety Disclosures		26

Item 5: Other Information		26

Item 6: Exhibits and Reports on Form 8-K		26

SIGNATURE		27

CERTIFICATIONS

[The balance of this page has been intentionally left blank.]

Table of Contents

PART I-FINANCIAL INFORMATION

Item 1. Financial Statements

United States Antimony Corporation and Subsidiaries
Condensed Consolidated Balance Sheets (Unaudited)
September 30, 2021 and December 31, 2020
ASSETS
	September 30, 2021			December 31, 2020
Current assets:
Cash and cash equivalents	$	21,563,500		$	665,102
Certificates of deposit		44,028			254,212
Accounts receivable		722,727			238,634
Inventories (Note 5)		733,956			650,213
Total current assets		23,064,211			1,808,161

Properties, plants and equipment, net (Note 13)		11,176,469			11,225,594
Restricted cash for reclamation bonds		57,275			57,275
IVA receivable and other assets		239,084			208,472
Total assets	$	34,537,039		$	13,299,502

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Checks issued and payable	$	-		$	86,685
Accounts payable		1,252,846			1,876,874
Accrued liabilities (Note 6)		571,209			635,626
Payables to related party (Note 9)		-			227,432
Notes payable to bank (Note 7)		-			100,000
Export tax assessment payable (Note 11)		-			1,120,730
Hillgrove advances payable (Note 12)		-			378,074
Long-term debt, current portion (Note 8)		-			52,122
Total current liabilities		1,824,055			4,477,543

Long-term debt, net of current portion (Note 8)		-			34,304
Hillgrove advances payable (Note 12)		-			756,147
CARES Act note payable (Note 14)		-			443,400
Stock payable to directors for services (Note 10)		84,375			110,000
Asset retirement obligations and accrued reclamation costs		296,916			291,719
Total liabilities		2,205,346			6,113,113
Commitments and contingencies (Note 6 and 11)

Stockholders' equity:
Preferred stock $0.01 par value, 10,000,000 shares authorized:
Series A: -0- shares issued and outstanding		-			-
Series B: 750,000 shares issued and outstanding (liquidation preference $945,000 and $937,500 respectively)		7,500			7,500
Series C: 177,904 shares issued and outstanding (liquidation preference $97,847 both years)		1,779			1,779
Series D: 1,751,005 shares issued and outstanding (liquidation preference $5,084,770 and $5,043,622 respectively)		17,509			17,509
Common stock, $0.01 par value, 150,000,000 shares authorized; 106,117,844 and 75,949,757 shares issued and outstanding, respectively		1,061,177			759,496
Additional paid-in capital		63,992,101			39,050,899
Accumulated deficit		(32,748,373	)		(32,650,794	)
Total stockholders' equity		32,331,693			7,186,389
Total liabilities and stockholders' equity	$	34,537,039		$	13,299,502

The accompanying notes are an integral part of the condensed consolidated financial statements.

Table of Contents

United States Antimony Corporation and Subsidiaries
Condensed Consolidated Statements of Operations - Unaudited

	For the three months ended						For the nine months ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020

REVENUES	$	2,051,713		$	1,007,231		$	5,580,562		$	4,335,413

COST OF REVENUES		1,950,504			1,442,322			5,070,798			4,685,388

GROSS PROFIT (LOSS)		101,209			(435,091	)		509,764			(349,975	)

OPERATING EXPENSES:
General and administrative		112,744			110,051			572,905			429,973
Salaries and benefits		72,200			82,308			226,137			288,455
Site care and maintenance expenses		-			-			184,037			24,250
Professional fees		28,227			43,557			212,563			161,167
Loss on abandonment of mineral properties		-			318,502			-			318,502
TOTAL OPERATING EXPENSES		213,171			554,418			1,195,642			1,222,347

LOSS FROM OPERATIONS		(111,962	)		(989,509	)		(685,878	)		(1,572,322	)

OTHER INCOME (EXPENSE):
Interest income		13,320			19			35,202			854
Interest expense		(590	)		(3,750	)		(3,725	)		(14,937	)
Gain on forgiveness of CARES Act debt (Note 14)		-			-			443,400			-
Grant income		-			-			-			10,000
Gain on settlement of Hillgrove advance (Note 12)		-			-			113,422			-
TOTAL OTHER INCOME (EXPENSE)		12,730			(3,731	)		588,299			(4,083	)

NET LOSS		(99,232	)		(993,240	)		(97,579	)		(1,576,405	)
Preferred dividends		(12,162	)		(12,162	)		(36,487	)		(36,487	)

Net loss available to common stockholders	$	(111,394	)	$	(1,005,402	)	$	(134,066	)	$	(1,612,892	)

Net loss per share of
common stock:
Basic and diluted	Nil			$	(0.01	)	Nil			$	(0.02	)

Weighted average shares outstanding:
Basic and diluted		106,117,844			73,240,218			101,642,048			71,033,733

The accompanying notes are an integral part of the condensed consolidated financial statements.

Table of Contents

United States Antimony Corporation and Subsidiaries
Condensed Consolidated Statement of Changes in Stockholders' Equity
For the periods ended September 30, 2021 and September 30, 2020
(Unaudited)

	Total Preferred Stock				Common Stock				Additional						Total
									Paid			Accumulated			Stockholders'
Three months ended September 30,2021	Shares		Amount		Shares		Amount		In Capital			Deficit			Equity

Balances, July 1, 2021		2,678,909	$	26,788		106,005,234	$	1,060,051	$	63,883,227		$	(32,649,141	)	$	32,320,925
Issuance of common stock to Directors (Note 10)		-		-		112,610		1,126		108,874			-			110,000
Net loss		-		-		-		-		-			(99,232	)		(99,232	)
Balances, September 30, 2021		2,678,909	$	26,788		106,117,844	$	1,061,177	$	63,992,101		$	(32,748,373	)	$	32,331,693

	Total Preferred Stock				Common Stock				Additional						Total
									Paid			Accumulated			Stockholders'
Three months ended September 30,2020	Shares		Amount		Shares		Amount		In Capital			Deficit			Equity

Balances, July 1, 2020		2,678,909	$	26,788		70,206,899	$	702,068	$	37,295,259		$	(29,947,155	)	$	8,076,960
Issuance of common stock and warrants for cash		-		-		5,742,858		57,428		1,952,572			-			2,010,000
Common stock issuance costs		-		-		-		-		(196,932	)		-			(196,932	)
Net loss		-		-		-		-		-			(993,240	)		(993,240	)
Balances, September 30, 2020		2,678,909	$	26,788		75,949,757	$	759,496	$	39,050,899		$	(30,940,395	)	$	8,896,788

	Total Preferred Stock				Common Stock				Additional						Total
									Paid			Accumulated			Stockholders'
Nine months ended September 30,2021	Shares		Amount		Shares		Amount		In Capital			Deficit			Equity

Balances, January 1, 2021		2,678,909	$	26,788		75,949,757	$	759,496	$	39,050,899		$	(32,650,794	)	$	7,186,389
Issuance of common stock for cash (Note 10)		-		-		26,290,000		262,900		24,734,100			-			24,997,000
Issuance of common stock to Directors (Note 10)		-		-		112,610		1,126		108,874			-			110,000
Common stock issuance costs (Note 10)		-		-		-		-		(1,654,820	)		-			(1,654,820	)
Common stock issued upon exercise of warrants (Note 10)		-		-		3,765,477		37,655		1,753,048			-			1,790,703
Net loss		-		-		-		-		-			(97,579	)		(97,579	)
Balances, September 30, 2021		2,678,909	$	26,788		106,117,844	$	1,061,177	$	63,992,101		$	(32,748,373	)	$	32,331,693

	Total Preferred Stock				Common Stock				Additional						Total
									Paid			Accumulated			Stockholders'
Nine months ended September 30,2020	Shares		Amount		Shares		Amount		In Capital			Deficit			Equity

Balances, January 1, 2020		2,678,909	$	26,788		69,661,436	$	696,614	$	37,107,730		$	(29,363,990	)	$	8,467,142
Issuance of common stock upon exercise of warrants		-		-		250,000		2,500		60,000			-			62,500
Issuance of common stock to Directors		-		-		295,463		2,954		127,529			-			130,483
Issuance of common stock and warrants for cash		-		-		5,742,858		57,428		1,952,572			-			2,010,000
Common stock issuance costs		-		-		-		-		(196,932	)		-			(196,932	)
Net loss		-		-		-		-		-			(1,576,405	)		(1,576,405	)
Balances, September 30, 2020		2,678,909	$	26,788		75,949,757	$	759,496	$	39,050,899		$	(30,940,395	)	$	8,896,788

The accompanying notes are an integral part of the condensed consolidated financial statements.

Table of Contents

United States Antimony Corporation and Subsidiaries
Condensed Consolidated Statements of Cash Flows - Unaudited
	For the nine months ended
Cash Flows From Operating Activities:	September 30, 2021			September 30, 2020
Net loss	$	(97,579	)	$	(1,576,405	)
Adjustments to reconcile net loss to net cash provided (used) by operating activities:
Depreciation and amortization		665,604			667,298
Loss on abandonment of mineral properties					318,502
Accretion of asset retirement obligation		5,197			6,118
Common stock payable for directors fees		84,375			89,858
Gain on settlement of Hillgrove advance		(113,422	)		-
Gain on forgiveness of Cares Act debt		(443,400	)		-
Other non-cash items		-			(661	)
Change in:
Accounts receivable		(484,093	)		62,399
Inventories		(83,743	)		61,194
IVA receivable and other assets		(30,612	)		10,119
Accounts payable		(624,028	)		(252,183	)
Accrued liabilities		(64,417	)		25,769
Export tax assessment payable		(1,120,730	)		-
Payables to related parties		(171,016	)		21,405
Net cash used by operating activities		(2,477,864	)		(566,587	)

Cash Flows From Investing Activities:
Proceeds from redemption of certificates of deposit		210,184			-
Purchase of properties, plants and equipment		(616,479	)		(220,455	)
Net cash used by investing activities		(406,295	)		(220,455	)

Cash Flows From Financing Activities:
Change in checks issued and payable		(86,685	)		(2,879	)
Net proceeds from (payments to) factor		-			(5,032	)
Payments on advances from related party		(56,416	)		(64,650	)
Proceeds from note payable-SBA		-			443,400
Proceeds from issuance of common stock, net of issuance costs		23,342,180			1,813,068
Proceeds from exercise of warrants		1,790,703			-
Payments on Hillgrove advances payable		(1,020,799	)		-
Borrowing on notes payable to bank		-			(46,270	)
Principal paid on notes payable to bank		(100,000	)		-
Principal payments of long-term debt		(86,426	)		(30,876	)
Net cash provided by financing activities		23,782,557			2,106,761
NET INCREASE IN CASH AND CASH
EQUIVALENTS AND RESTRICTED CASH		20,898,398			1,319,719
Cash and cash equivalents and restricted cash at beginning of period		722,377			172,767
Cash and cash equivalents and restricted cash at end of period	$	21,620,775		$	1,492,486

NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock payable issued to directors (Note 10)	$	110,000		$	130,483
Payable to related party satisfied with issuance of stock (Note 10)	$	-		$	62,500

The accompanying notes are an integral part of the condensed consolidated financial statements.

Table of Contents

PART I - FINANCIAL INFORMATION, CONTINUED:

United States Antimony Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

1.	Basis of Presentation

	The unaudited consolidated financial statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America for interim financial information, as well as the instructions to Form 10‑Q. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of the Company’s management, all adjustments (consisting of only normal recurring accruals) considered necessary for a fair presentation of the interim financial statements have been included. Operating results for the three and nine month periods ended September 30, 2021 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2021. For further information refer to the financial statements and footnotes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. Going Concern Consideration At September 30, 2021, the Company’s condensed consolidated financial statements show working capital of approximately $21.2 million and an accumulated deficit of approximately $32.7 million. The Company has incurred losses for the past two fiscal years which are principally a result of the Company’s antimony operations due to both depressed antimony prices and production costs incurred in Mexico. To improve conditions, the Company continues searching for areas to reduce these production costs. In the nine months of 2021, the Company raised net proceeds of approximately $23.3 million from sale of shares of its common stock and approximately $1.8 million from the exercise of stock purchase warrants. These funds have been and will continue to be used for general corporate purposes, working capital, hiring of additional labor, leverage for reducing legacy contracts, additional managerial staff at United States Antimony Corporation (“USAC”) and Bear River Zeolite (“BRZ”) headquarters, a revised website including measures aimed at increased visibility for advertising, more labor at its Mexican smelter, repair and improved infrastructure at the Mexican smelter, potential securement of additional antimony mine reserves in Mexico, and improvement of furnaces in Montana. With the funds raised, management believes the Company has sufficient funds to sustain its operations and meet its financial obligations during the twelve months following the date of issuance of these condensed consolidated financial statements.

Developments in Accounting Pronouncements

Accounting Standards Updates Adopted

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The update contains a number of provisions intended to simplify the accounting for income taxes. The update was adopted as of January 1, 2021, and its adoption did not have a material impact on the Company’s condensed consolidated financial statements.

Table of Contents

United States Antimony Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

2.	Developments in Accounting Pronouncements, Continued:

Accounting Standards Updates to Become Effective in Future Periods

In August 2020, the FASB issued ASU No.2019-12 Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The update is to address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. The update is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years and with early adoption permitted. Management is evaluating the impact of this update on the Company’s condensed consolidated financial statements.

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the condensed consolidated financial statements upon adoption.

Income (Loss) Per Common Share

Basic earnings per share is calculated by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible preferred stock.

At September 30, 2021 and 2020, the potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive are as follows:

	September 30, 2021		September 30, 2020
Warrants		12,489,922		6,194,899
Convertible preferred stock		1,751,005		1,751,005
Total possible dilution		14,240,927		7,945,904

4.	Revenue Recognition

	Products consist of the following:

	·	Antimony: includes antimony oxide, sodium antimonate, antimony trisulfide, and antimony metal
	·	Zeolite: includes coarse and fine zeolite crushed in various sizes
	·	Precious Metals: includes unrefined and refined gold and silver

Table of Contents

United States Antimony Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

4.	Revenue Recognition, Continued:

	Sales of products for the three and nine month periods ended September 30, 2021 and 2020 were as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Antimony	$	1,284,969	$	477,273	$	3,371,015	$	2,509,183
Zeolite		693,008		481,126		1,929,383		1,653,201
Precious metals		73,736		48,832		280,164		173,029
	$	2,051,713	$	1,007,231	$	5,580,562	$	4,335,413

The following is sales information by geographic area based on the location of customers for the three and nine month periods ended September 30, 2021 and 2020:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
United States	$	1,805,456	$	891,090	$	4,954,412	$	3,893,374
Canada		246,257		116,141		626,150		442,039
	$	2,051,713	$	1,007,231	$	5,580,562	$	4,335,413

Sales of products to significant customers were as follows for the three and nine month periods ended September 30, 2021 and 2020:

	For the Three Months Ended						For the Nine Months Ended
Sales to	September 30,			September 30,			September 30,			September 30,
Largest Customers	2021			2020			2021			2020
Company A		288,640			114,075			778,211			404,447
Company B		581,609			105,865			1,284,206			-
Company C		-			-			518,226			523,660
Company D		225,800			-			225,800			-
Company E		-			131,360			-			345,899
	$	1,096,049		$	351,300		$	2,806,443		$	1,274,006
% of Total Revenues		53.42	%		34.88	%		50.29	%		29.39	%

At September 30, 2021, the Company had a sales order backlog of 1,192 tons of zeolite and 44,092 pounds of antimony.

Table of Contents

United States Antimony Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

4.	Revenue Recognition, Continued:

Accounts receivable from largest customers were as follows at September 30, 2021 and December 31, 2020:

Largest
Accounts Receivable	September 30, 2021			December 31, 2020
Company B	$	222,100		$	-
Company F		110,864			-
Company G		54,400			68,055
Company H		-			21,619
Company I		-			16,600
Company J		-			12,255
	$	387,364		$	118,529
% of Total Receivables		53.60	%		49.67	%

Our trade accounts receivable balance related to contracts with customers was $722,727 at September 30, 2021 and $238,634 at December 31, 2020. Our products do not involve any warranty agreements and product returns are not typical.

5.	Inventories

	Inventories at September 30, 2021 and December 31, 2020 consisted primarily of finished antimony products, antimony metal, antimony ore, and finished zeolite products that are stated at the lower of first-in, first-out cost or estimated net realizable value. Finished antimony products, antimony metal and finished zeolite products costs include raw materials, direct labor and processing facility overhead costs and freight. Inventories at September 30, 2021 and December 31, 2020 are as follows:

	September 30, 2021		December 31, 2020
Antimony Metal	$	116,325	$	268,100
Antimony Oxide		214,659		67,377
Antimony Ore		211,788		95,880
Total antimony		542,772		431,357
Zeolite		191,184		218,856
	$	733,956	$	650,213

Antimony oxide inventory consisted of finished product oxide held at the Company’s plants in Montana and Mexico. Antimony concentrates and ore were held primarily at sites in Mexico and are essentially raw material. The Company’s zeolite inventory consists of salable zeolite material.

As of September 30, 2021 and December 31, 2020, all inventory is valued at cost except for antimony ore inventory in Mexico which was valued at net realizable value as of December 31, 2020.

Table of Contents

United States Antimony Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

6.	Commitments and Contingencies

	The Company pays various royalties on the sale of zeolite products. On a combined basis, royalties vary from 8%-13%. During the three and nine month periods ended September 30, 2021, the Company had royalty expense of $64,212 and $195,779, respectively. During the three and nine month periods ended September 30, 2020, the Company had royalty expense of $52,569 and $178,187, respectively. At September 30, 2021 and December 31, 2020, the Company had accrued royalties payable of $376,704 and $434,981, respectively, which is included in accrued liablities. The Company is currently in negotiations with certain royalty holders to modify the terms of the agreements.

7.	Notes Payable to Bank

	At September 30, 2021 and December 31, 2020, the Company had the following notes payable to bank:

	2021		2020
Promissory note payable to First Security Bank of Missoula,
bearing interest at 3.150%, payable on demand, collateralized
by a lien on Certificate of Deposit	$	-	$	99,999

Promissory note payable to First Security Bank of Missoula,
bearing interest at 3.150%, payable on demand, collateralized
by a lien on Certificate of Deposit		-		1

Total notes payable to the bank	$	-	$	100,000

The notes are paid in full as of September 30, 2021 and the lien on the Certificate of Deposit has been released. An amount of $210,184 of the Certificate of Deposit was released during the nine months ended September 30, 2021 and the cash was transferred to the checking account, leaving a Certificate of Deposits balance of $44,028 at September 30, 2021 compared to $254,212 at December 31, 2020.

Table of Contents

United States Antimony Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited), Continued:

8.	Debt

	Long-Term debt at September 30, 2021 and December 31, 2020 is as follows:

	September 30,		December 31,
	2021		2020
Note payable to Zeo Inc., non interest bearing,
payable in 11 quarterly installments of $8,300 with a final payment of $8,700;
maturing December 2022; uncollateralized.	$	-	$	66,800
Note payable to Cat Financial Services, bearing interest at 6%;
payable in monthly installments of $778; maturing
December 2022; collateralized by equipment.		-		17,480
Note payable to Phyllis Rice, bearing interest
at 1%; payable in monthly installments of $2,000; originally maturing
March 2015; collateralized by equipment.		-		2,146
		-		86,426
Less current portion		-		(52,122	)
Long-term portion	$	-	$	34,304

Related Party Transactions

The Company’s previous President and Chairman, John Lawrence, rented equipment to the Company and charged the Company for lodging and meals provided to consultants, customers and other parties by an entity that Mr. Lawrence owned. The amount due to Mr. Lawrence’s estate as of September 30, 2021 and December 31, 2020 was $nil and $171,017. During the nine months ended September 30, 2021, the Company paid off the full amount of $171,017 to John Lawrence’s estate for reimbursement of these expenses.

During 2019, Mr. Lawrence advanced funds to the Company that had a balance at December 31, 2020 of $56,215. During the nine month period ended September 30, 2021, the Company paid First Security Bank on behalf of Mr. Lawrence $56,215. The balance of the advances due to Mr. Lawrence at September 30, 2021 is $nil.

John C. Gustavsen, Interim CEO of the Company, has an advance due from the Company of $200 at December 31, 2020. During the nine month period ended September 30, 2021, the Company paid $200 to Mr. Gustavsen as reimbursement on these advances.

During the nine months ended September 30, 2021, Russ Lawrence, Interim President & Director, incurred expenses of $18,487 and charged the Company for lodging and meals provided to visiting Board of Directors by an entity that Russ Lawrence owns. During the nine month period ended September 30, 2021, the Company paid Russ Lawrence $17,740, leaving a balance due of $747 which is included in accounts payable on the balance sheet.

Table of Contents

United States Antimony Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited), Continued:

10.

Stockholder’s Equity

In February 2021, the Company sold shares of its common stock in two separate transactions: On February 3, 2021, 15,300,000 shares were sold at $0.70 for gross proceeds of $10,710,000; and on February 18, 2021, 10,990,000 shares were sold at at $1.30 for gross proceeds of $14,287,000. A total of $1,654,820 of cash issuance costs were incurred on these sales.

During the nine months ended September 30, 2021, the Company accrued $84,375 in directors’ fees payable that will be paid in common stock.

During the nine months ended September 30, 2021, the Company issued 112,610 shares of common stock to the board of director’s to satisfy the directors’ fees payable of $110,000 that were outstanding at December 31, 2020.

During the nine month period ended September 30, 2021, the Company issued 3,765,477 shares of common stock and received $1,790,703 in cash from the exercise of warrants. For the same period in 2020, the Company’s former president, John Lawrence, exercised warrants for 250,000 shares of common stock in exchange for a payable due to him of $62,500.

Warrants

Concurrent with the February 3, 2021 sale of common stock, the Company sold warrants to purchase 7,650,000 shares of common stock at an exercise price of $0.85 per share. The warrants are initially exercisable six months following issuance and expire five and one-half years from the issuance date. In connection with the February 2021 sales of common stock, the Company also issued 1,606,500 warrants with an exercise price of $0.85 and 804,000 warrants with an exercise price of $0.46 as commission to the placement agent.

Transactions in common stock purchase warrants for the nine month period ended September 30, 2021 and the year ended December 31, 2020 are as follows:

	Number of Warrants			Exercise Prices
Balance December 31, 2019		702,041		$	0.25 - $0.65
Issued		5,742,858		$	0.46
Exercised		(250,000	)	$	0.25
Balance December 31, 2020		6,194,899		$	0.46 - $0.65
Issued		10,060,500		$	0.46- $0.85
Exercised		(3,765,477	)	$	0.46 - $0.65
Balance September 30, 2021		12,489,922		$	0.46 - $0.85

These warrants expire as follows:

Warrants		Exercise Price		Expiration Date
	143,707	$	0.65	2022
	2,285,715	$	0.46	2026
	9,256,500	$	0.85	2026
	804,000	$	0.46	2026
	12,489,922

Table of Contents

United States Antimony Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited), Continued:

11.

Income and Other Taxes

Mexican Tax Assessment

In 2015, the Mexican tax authority (“SAT”) initiated an audit of the USAMSA’s 2013 income tax return. In October 2016, as a result of its audit, SAT assessed the Company $13.8 million pesos, which was approximately $666,400 in U.S. Dollars (“USD”) as of December 31, 2016. SAT’s assessment was based on the disallowance of specific costs that the Company deducted on the 2013 USAMSA income tax return. The Company engaged accountants and tax attorneys in Mexico to defend its position. The assessment was settled in 2018 with no assessment against the Company.

In early 2019, the Company was notified that SAT re-opened its audit of USAMSA’s 2013 income tax return and, in November 2019, SAT assessed the Company $16.3 million pesos, which was approximately $818,000 USD as of September 30, 2021. Management reviewed the 2019 assessment notice from SAT and, similar to the earlier assessment, believes the findings have no merit. The Company engaged a tax attorney in Mexico to defend its position. An appeal was filed by the Company in November 2019 suspending SAT from taking immediate action regarding the assessment. The Company posted a guarantee of the amount in March 2020 as is required under the appeal process. In August 2020, the Company filed a lawsuit against SAT for resolution of the process and, in December 2020, filed closing arguments. Management expects the appeal process to continue through 2021.

At September 30, 2021 and December 31, 2020, management assessed the possible outcomes for this tax audit and believes, based on discussions with its tax attorney in Mexico, that the most likely outcome will be that the Company will be successful in its appeal resulting in no tax due. Management determined that no amount should be accrued at September 30, 2021 and December 31, 2020 relating to this potential tax liability. There can be no assurance that the Company’s ultimate liability, if any, will not have a material adverse effect on the Company’s results of operations or financial position. If an issue addressed during the SAT audit is resolved in a manner inconsistent with management expectations, the Company will adjust its current net operating loss carryforward, or accrue penalties, interest, and tax associated with the assessment.

Other Taxes

In 2016, USAMSA imported coal from the United States to its smelter in Mexico to process Australian concentrates associated with the Hillgrove agreement (Note 12). At that time, the Company applied for and was granted a Maquiladora (IMMEX), in accordance with a Manufacturing and Export Services Industry program offered by the Mexican government to attract and promote foreign investment in Mexico. With the IMMEX, all imported goods to Mexico that are also exported in altered form are exempt from the requirement of paying the 16% tax (IVA). The Company did not pay IVA on any of the imported coal used to process the Australian concentrates. In 2020, the Company was informed by the SAT that it owed the 16% IVA money for all the coal imported for the processing of the Australian concentrates. Additionally, there were penalties and fees that SAT added to the total amount. In late 2020, the Company filed a motion before the Taxpayer’s Defense Agency (PRODECON), but the motion was denied. To avoid exorbitant penalties, the Company elected to pay the assessed amount in early 2021. For the year ended December 31, 2020, the Company recognized an export tax expense of $1,120,730 and accrued a liability for this assessment. The assessment was settled with a payment of $1,120,730 during the three month period ended March 31, 2021.

Table of Contents

United States Antimony Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited), Continued:

12.	Hillgrove Advances Payable

	On November 7, 2014, the Company entered into an advance and concentrate processing agreement with Hillgrove Mines Pty Ltd of Australia (Hillgrove) in which the Company was advanced funds from Hillgrove to build facilities to process Hillgrove antimony concentrate. The Company has not processed Hillgrove concentrate for more than two years. The agreement requires the Company to pay the advance balance after Hillgrove issues a stop notice. Payments would begin 90 days after the stop notice issue date and be made in six equal and quarterly installments. Hillgrove was acquired by Red River Resources LTD (“Red River”) during 2019. The balance of the advance liability due was $1,134,221 at December 31, 2020. In April 2021, the Company successfully negotiated a settlement with Red River for an agreed upon amount of $1,020,799 which was paid on paid on April 8, 2021. The Company recognized a gain on settlement of the advance in the amount of $113,422 during the three month period ended June 30, 2021.

13.

Business Segments

The Company is currently organized and managed by four segments, which represent our operating units: United States antimony operations, Mexican antimony operations, precious metals recovery and United States zeolite operations.

The Puerto Blanco mill and the Madero smelter at the Company’s Mexico operation bring antimony up to an intermediate or finished stage, which may be sold directly or shipped to the United States operation for finishing at the Thompson Falls, Montana plant. The Puerto Blanco mill in Mexico is the site of our crushing and flotation plant, and a cyanide leach plant which will recover precious metals after the ore goes through the crushing and flotation cycles. A precious metals recovery plant is operated in conjunction with the antimony processing plant at Thompson Falls, Montana, where a 99% precious metals mix will be produced. The zeolite operation produces zeolite near Preston, Idaho. Almost all of the sales of products from the United States antimony and zeolite operations are to customers in the United States, although the Company does have a sales operation in Canada.

Segment disclosure regarding sales to major customers is located in Note 4.

Properties, plants and equipment, net:	September 30, 2021		December 31, 2020
Antimony
United States	$	1,617,981	$	1,637,738
Mexico		7,215,048		7,635,410
Subtotal Antimony		8,833,029		9,273,148
Precious metals		904,647		933,885
Zeolite		1,438,791		1,018,561
Total	$	11,176,469	$	11,225,594

At September 30, 2021 and December 31, 2020, the Company had $807,471 and $755,978, respectively, of assets that were not yet placed in service and have not yet been depreciated.

Table of Contents

United States Antimony Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited), Continued:

13.

Business Segments, Continued:

	For the Three Months Ended				For the Nine Months Ended
Capital expenditures:	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Antimony
United States	$	4,060	$	-	$	4,060	$	32,448
Mexico		4,872		2,923		14,616		33,585
Subtotal Antimony		8,932		2,923		18,676		66,033
Precious Metals		17,607		17,366		54,954		138,211
Zeolite		474,812		-		542,849		16,211
Total	$	501,351	$	20,289	$	616,479	$	220,455

Segment Operations for the three	Antimony			Antimony			Total			Precious		Bear River
months ended September 30, 2021	USAC			Mexico			Antimony			Metals		Zeolite			Totals

Total revenues	$	1,284,969		$	-		$	1,284,969		$	73,736	$	693,008		$	2,051,713

Depreciation and amortization		8,032			145,027			153,059			28,361		41,776			223,196

Income (loss) from operations		528,750			(673,739	)		(144,989	)		45,375		(12,348	)		(111,962	)

Other income (expense):		13,249			-			13,249			-		(519	)		12,730

NET INCOME (LOSS)	$	541,999		$	(673,739	)	$	(131,740	)	$	45,375	$	(12,867	)	$	(99,232	)

Segment Operations for the three	Antimony			Antimony			Total			Precious		Bear River
months ended September 30, 2020	USAC			Mexico			Antimony			Metals		Zeolite			Totals

Total revenues	$	477,273		$	-		$	477,273		$	48,832	$	481,126		$	1,007,231

Depreciation and amortization		7,395			146,099			153,494			22,141		42,015			217,650

Income (loss) from operations		(208,676	)		(904,337	)		(1,113,013	)		26,691		96,813			(989,509	)

Other income (expense):		(2,883	)		(4	)		(2,887	)		-		(844	)		(3,731	)

NET INCOME (LOSS)	$	(211,559	)	$	(904,341	)	$	(1,115,900	)	$	26,691	$	95,969		$	(993,240	)

Table of Contents

United States Antimony Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited), Continued:

13.

Business Segments, Continued:

Segment Operations for the nine	Antimony			Antimony			Total			Precious		Bear River
months ended September 30, 2021	USAC			Mexico			Antimony			Metals		Zeolite			Totals

Total revenues	$	3,371,015		$	-		$	3,371,015		$	280,164	$	1,929,383		$	5,580,562

Depreciation and amortization		23,816			434,978			458,794			84,191		122,619			665,604

Income (loss) from operations		409,723			(1,487,670	)		(1,077,947	)		195,973		196,096			(685,878	)

Other income (expense):		476,609			113,422			590,031			-		(1,732	)		588,299

NET INCOME (LOSS)	$	886,332		$	(1,374,248	)	$	(487,916	)	$	195,973	$	194,364		$	(97,579	)

Segment Operations for the nine	Antimony			Antimony			Total			Precious		Bear River
months ended September 30, 2020	USAC			Mexico			Antimony			Metals		Zeolite			Totals

Total revenues	$	2,509,183		$	-		$	2,509,183		$	173,029	$	1,653,201		$	4,335,413

Depreciation and amortization		22,184			438,297			460,481			66,422		140,395			667,298

Income (loss) from operations		156,884			(2,182,979	)		(2,026,095	)		106,607		347,166			(1,572,322	)

Other income (expense):		(1,058	)		(4	)		(1,062	)		-		(3,021	)		(4,083	)

NET INCOME (LOSS)	$	155,826		$	(2,182,983	)	$	(2,027,157	)	$	106,607	$	344,145		$	(1,576,405	)

Table of Contents

United States Antimony Corporation and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited), Continued:

14.

Note Payable-Small Business Administration Loan

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (the “CARES Act”) Act was signed into United States law.

On April 20, 2020, the Company received a loan of $443,400 pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the CARES Act, which was enacted March 27, 2020. The loan, which was in the form of a Note dated April 20, 2020 had a maturity date on April 19, 2022 and an interest rate of 1% per annum. The loan was to be forgiven under the provisions of the CARES Act if the Company used the funds for qualifying expenses. Qualifying expenses included payroll costs, costs used to continue group health care benefits, rent, and utilities. During the three month period ended June 30, 2021, the Company received notification that the loan had been forgiven. The amount of the loan, $443,400, was recognized as gain on forgiveness of the CARES Act loan.

Table of Contents

ITEM 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition

COVID-19 Coronavirus Pandemic Response and Impact

One of the principal challenges facing the Company in 2021 as a result of stimulus funding from Covid-19 has been the evaporation of available labor. This issue has seriously impacted both operations in Montana and at its zeolite operation in Idaho. The following measures are being taken in an attempt to obtain and retain laborers:

	1.	The Company has raised the starting wage both in Montana and Idaho and as a result increased its labor costs for existing laborers.
	2.	The Company has advertised on multiple job search platforms and is also advertising in two languages on conventional job search platforms as well as on multiple social media sites.
	3.	The Company is increasing capacity at the Mexican smelter where labor is not a problem.
	4.	The Company is investigating hiring from alternative potential labor pools.

It is difficult to hire people if they are getting paid more not to work, which is the reality in many cases but is hopeful that the situation(s) fueling this crisis will end soon.

General

Certain matters discussed are forward-looking statements that involve risks and uncertainties, including the impact of antimony prices and production volatility, changing market conditions and the regulatory environment and other risks. Actual results may differ materially from those projected. These forward-looking statements represent our judgment as of the date of this filing. We disclaim, however, any intent or obligation to update these forward-looking statements.

Table of Contents

PART I - FINANCIAL INFORMATION, CONTINUED:

ITEM 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition, continued:

	Three Months			Three Months			Nine Months			Nine Months
	Ended			Ended			Ended			Ended
Antimony - Combined USA and Mexico	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
Lbs of Antimony Metal USA		306,045			89,052			817,131			375,519
Lbs of Antimony Metal Mexico:		-			57,790			10,000			300,474
Total Lbs of Antimony Metal Sold		306,045			146,842			827,131			675,993
Average Sales Price/Lb Metal	$	4.20		$	3.25		$	4.08		$	3.71
Net loss/Lb Metal	$	(0.43	)	$	(7.60	)	$	(0.59	)	$	(3.00	)

Gross antimony revenue - net of discount		1,284,969			477,273			3,371,015			2,509,183

Cost of sales - domestic		(585,875	)		(491,092	)		(2,080,987	)		(1,559,018	)
Cost of sales - Mexico		(654,380	)		(557,399	)		(1,220,069	)		(1,805,127	)
Operating expenses		(189,703	)		(223,293	)		(1,147,906	)		(852,631	)
Non-operating income (expenses)		13,249			(2,887	)		590,031			(1,062	)
Loss on abandonment of mineral properties		-			(318,502	)		-			(318,502	)
		(1,416,709	)		(1,593,173	)		(3,858,931	)		(4,536,340	)

Net loss - antimony		(131,740	)		(1,115,900	)		(487,916	)		(2,027,157	)
Depreciation,& amortization		153,059			153,494			458,794			460,181
EBITDA - antimony	$	21,319		$	(962,406	)	$	(29,122	)	$	(1,566,976	)

Precious Metals
Ounces sold
Gold		12			6			34			31
Silver		5,638			2,403			15,246			11,434

Gross precious metals revenue	$	73,736		$	48,832		$	280,164		$	173,029
Cost of sales		(28,361	)		(22,141	)		(84,191	)		(66,422	)
Net income - precious metals		45,375			26,691			195,973			106,607
Depreciation		28,361			22,141			84,191			66,422
EBITDA - precious metals	$	73,736		$	48,832		$	280,164		$	173,029

Zeolite
Tons sold		3,045			2,500			8,823			8,354
Average Sales Price/Ton	$	227.59		$	192.45		$	218.68		$	197.89
Net income (Loss)/Ton	$	(4.23	)	$	38.39		$	22.03		$	41.20

Gross zeolite revenue	$	693,008		$	481,126		$	1,929,383		$	1,653,201
Cost of sales		(681,888	)		(371,690	)		(1,685,551	)		(1,254,821	)
Operating expenses		(23,468	)		(12,623	)		(47,736	)		(51,214	)
Non-operating expenses		(519	)		(844	)		(1,732	)		(3,021	)
Net income (loss) - zeolite		(12,867	)		95,969			194,364			344,145
Depreciation		41,776			42,015			122,619			140,395
EBITDA - zeolite	$	28,909		$	137,984		$	316,983		$	484,540

Company-wide
Gross revenue	$	2,051,713		$	1,007,231		$	5,580,562		$	4,335,413
Production costs		(1,950,504	)		(1,442,322	)		(5,070,798	)		(4,685,388	)
Operating expenses		(213,171	)		(235,916	)		(1,195,642	)		(903,845	)
Non-operating income (expenses)		12,730			(3,731	)		588,299			(4,083	)
Loss on abandonment of mineral properties		-			(318,502	)		-			(318,502	)
Net loss		(99,232	)		(993,240	)		(97,579	)		(1,576,405	)
Depreciation,& amortization		223,196			217,650			665,604			667,298
EBITDA	$	123,964		$	(775,590	)	$	568,025		$	(909,107	)

Certain amounts shown in this table may not add exactly to total amounts due to rounding differences

Table of Contents

PART I - FINANCIAL INFORMATION, CONTINUED:

ITEM 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition, continued:

Company-Wide

For the third quarter of 2021, we recognized a net loss of $99,232 on sales of $2,051,713 and other income and expense of $12,730 after depreciation and amortization of $223,196. We reported a net loss of $993,240 in the third quarter of 2020 on sales of $1,007,231, after depreciation and amortization of $217,650.

For the first nine months of 2021, we recognized a net loss of $97,579 on sales of $5,580,562 and other income and expense of $588,299, after depreciation and amortization of $665,604. We reported a net loss of $1,576,405 for the first nine months of 2020 on sales of $4,335,413, after depreciation and amortization of $667,298.

For the three and nine months ended September 30, 2021, EBITDA was a positive $123,964 and $568,025 compared to a negative $775,590 and $909,107 for the same periods in 2020.

For the three and nine months ended September 30, 2021, general and administrative expenses were $112,744 and $572,905 compared to $110,051 and $429,973 for the same periods of 2020.

Antimony

Antimony has been the focus of the Company since its inception. China, historically the sole supplier of lump antimony trisulfide and the dominate supplier of antimony in general, has held back the export of all antimony products leading to a marked increase in price in 2021.

The Madero crew continued to produce crude antimony oxide and some of this production was simultaneously diverted to crude metal. While the price is high the Company has decided to convert some of its crude oxide to finished metal. This move will eliminate shipping charges for the finished metal as the product will be shipped directly to the customer.

Two new furnaces in Thompson Falls are fully operational and started producing test batches of antimony trisulphide in early October. Throughput nameplate capacity of antimony trisulphide will increase from 100 lbs per day to approximately 1100 lbs per day. A second sample of antimony trisulfide lump has been prepared and sent for grinding and laboratory analysis. If the quality meets specifications, the second sample will be sent to the Picatinny Arsenal of the U. S. Department of Defense.

The Company continues to track developments at Ambri, Inc. which has purchased the Company’s antimony metal during the year and may be a significant customer in the future.

For the three and nine month periods ended September 30, 2021, we sold 306,045 pounds and 827,131 pounds of antimony compared to 146,842 and 675,993 pounds for the three and nine month periods ended September 30, 2020. The raw material received from our North American supplier increased by approximately 64,077 and 238,195 pounds for the three and nine month periods ended September 30, 2021, compared to the same periods for 2020. We had an increase in raw material from Mexico of approximately 87,223 pounds for the three month period and a decrease of 86 pounds for the nine month period ended September 30, 2021, compared to the same periods for 2020.

Table of Contents

PART I - FINANCIAL INFORMATION, CONTINUED:

ITEM 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition, continued:

The average sales price of antimony during the three and nine month periods ended September 30, 2021 was $4.20 and $4.08 per pound compared to $3.25 and $3.71 during the same periods in 2020.

Precious Metals

Discussions have been initiated with Canadian and American gold and silver exploration companies, presently operating in Mexico, with a view towards a joint venture option agreement. A potential joint venture would ideally have existing personnel with experience in exploration for gold and silver in Mexico and would initially fund and manage the initial exploration programs as part of their earn-in requirement. Traditionally summer is a slow time for junior exploration companies and progress on negotiations has been slower than expected.

For the three and nine month periods ended September 30, 2021, revenue for precious metals from North American sources was $73,736 and $280,164 compared to $48,832 and $173,029 for the same periods of 2020.

Current and prior periods’ revenue from precious metals is as follows:

Precious Metal Sales Silver/Gold	For the three months ended September 30,				For the nine months ended September 30,
Montana	2021		2020		2021		2020
Ounces Gold Shipped (Au)		12		6		34		31
Ounces Silver Shipped (Ag)		5,638		2,403		15,246		11,434
Total Revenues	$	73,736	$	48,832	$	280,164	$	173,029

Bear River Zeolite (BRZ)

On August 12, 2021 the bearings went out on the primary jaw crusher, essentially shutting down production. The Company was able to source and purchase a refurbished jaw crusher, which shortened the down time that would have been required for repairs and dovetailed with the continuing program to upgrade the efficiency and reliability of the zeolite plant. Installation of the new jaw crusher was completed and online by September 3, 2021. Pit production test work utilizing a D-9 dozer to rip the in-situ zeolite instead of drilling and blasting continues. New uses and increased awareness of several of the recognized uses of zeolite are becoming known to the public. This is especially apparent in the advanced treatment requirements for mine discharge water and in the removal of naturally occurring radioactive isotopes in otherwise potable drinking water sources.

For the three and nine month periods ended September 30, 2021, BRZ sold 3,045 and 8,823 tons of zeolite compared to 2,500 and 8,354 tons in the same periods of 2020.

For the three and nine month periods ended September 30, 2021, BRZ realized a net loss of $12,867 and income of $194,364 after depreciation of $41,776 and $122,619 compared to a net income of $95,969 and $344,145 after depreciation of $42,015 and $140,395 for the same period of 2020.

BRZ realized an EBITDA for the three and nine month periods ended September 30, 2021 of $28,909 and $316,983 compared to $137,984 and $484,540 for the same periods in 2020.

Table of Contents

PART I - FINANCIAL INFORMATION, CONTINUED:

ITEM 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition, continued:

Financial Position

Financial Condition and Liquidity	September 30, 2021			December 31, 2020

Current assets	$	23,064,211		$	1,808,161
Current liabilities		(1,824,055	)		(4,477,543	)
Net Working Capital	$	21,240,156		$	(2,669,382	)

	For the Nine Months Ended
	September 30, 2021			September 30, 2020
Cash used by operations	$	(2,477,864	)	$	(566,587	)
Cash provided (used) by investing:
Cash used for capital outlay		(616,479	)		(220,455	)
Proceeds from redemption of certificates of deposit		210,184			-
Cash provided (used) by financing:
Net payments (to) from factor					(5,032	)
Payments on notes payable to bank		(100,000	)		(46,270	)
Payments on Hillgrove advances payable		(1,020,799	)		-
Proceeds from common stock issued, net		23,342,180			1,813,068
Proceeds from exercise of warrants		1,790,703			-
Principal paid on long-term debt		(86,426	)		(30,876	)
Payments on advances from related party		(56,416	)		(64,650	)
Proceeds from note payable-SBA		-			443,400
Change in checks issued and payable		(86,685	)		(2,879	)
Net change in cash, cash equivalents and restricted cash	$	20,898,398		$	1,319,719

Our net working capital increased by $23,909,538 from December 31, 2020 to September 30, 2021. Our cash and cash equivalents increased by $20,898,398 during the same period. We spent $616,479 for capital items, our debt decreased by $1,901,479 including $1,020,799 paid to Hillgrove, and our accounts payable and other accrued liabilities decreased by $1,895,860 including $1,120,730 paid for an export tax assessment. During the first nine months of 2021, we raised approximately $23.3 million from sale of shares of common stock and approximately $1.8 million for the exercise of warrants.

We have estimated commitments and improvements of less than $100,000 to finish building and installing the precious metals leach circuits. However, this funding will be implemented after its geological study of the Los Juarez property. The Company plans to conduct a proper study of the Los Juarez property and its tailings at its flotation plant and pending the results of these studies decide how to proceed regarding a drill program and/or mining of the property. The study may involve a partnership with a junior mining Company in order to assist US Antimony in the proper characterization of the deposit. Should the deposit be of great value, the Company will likely move the flotation plant closer to the mine. We believe that with our current cash balance, along with the future cash flow from operations and operating agreements, we have adequate liquid assets to meet these commitments and service our debt for the next twelve months.

Table of Contents

PART I - FINANCIAL INFORMATION, CONTINUED:

ITEM 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition, continued:

At September 30, 2021, the Company’s condensed consolidated financial statements show working capital of approximately $21.2 million and an accumulated deficit of approximately $32.7 million. The Company continues to search for areas to reduce production costs, and expects improvement in cash flow for the remainder of the year from the sale of antimony and zeolite along with the increased price of antimony as the price of antimony has been increasing during the past nine months.

In the first half of 2021, the Company raised net proceeds of approximately $23.3 million from sale of shares of its common stock and approximately $1.8 million from the exercise of stock purchase warrants. These funds have been and will continue to be used for general corporate purposes, working capital, hiring of additional labor, leverage for reducing legacy contracts, a geochemical, geological, and geophysical study of the Los Juarez property, additional managerial staff at USAC and BRZ headquarters, a revised website including measures aimed at increased visibility for advertising, more labor at its Mexican smelter, repair and improved infrastructure at the Mexican smelter, potential securement of additional antimony mine reserves in Mexico, and improvement of furnaces in Montana. With the funds raised, management believes the Company has sufficient funds to sustain its operations and meet its financial obligations during the 12 months following the date of issuance of these condensed consolidated financial statements.

ITEM 3.

None

ITEM 4. Controls and Procedures

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, as appropriate, to allow timely decisions regarding required disclosure. Our Interim President & Director conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) as of September 30, 2021. It was determined that there were material weaknesses affecting our disclosure controls and procedures and, as a result of those weaknesses, our disclosure controls and procedures were not effective as of September 30, 2021. These material weaknesses are as follows:

	·	Inadequate design of internal control over the preparation of the financial statements and financial reporting processes;
	·	Inadequate monitoring of internal controls over significant accounts and processes including controls associated with domestic and Mexican subsidiary operations and the period-end financial reporting process; and
	·	The absence of proper segregation of duties within significant processes and ineffective controls over management oversight, including antifraud programs and controls.

We are aware of these material weaknesses and will develop procedures to ensure that independent review of material transactions is performed. The Interim President & Director will develop internal control measures to mitigate the lack of inadequate documentation of controls and the monitoring of internal controls over significant accounts and processes including controls associated with the period-ending reporting processes,

Table of Contents

PART I - FINANCIAL INFORMATION, CONTINUED:

ITEM 4. Controls and Procedures, continued:

and to mitigate the segregation of duties within significant accounts and processes and the absence of controls over management oversight, including antifraud programs and controls.

We plan to consult with independent experts when complex transactions are entered into.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

There were no significant changes made to internal controls over financial reporting for the quarter ended September 30, 2021.

Table of Contents

PART II - OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

None

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

Item 3. DEFAULTS UPON SENIOR SECURITIES

The registrant has no outstanding senior securities.

Item 4. MINE SAFETY DISCLOSURES

The information concerning mine safety violations or other regulatory matters required by Section 1503 (a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K is included in Exhibit 95 to this Annual Report.

Item 5. OTHER INFORMATION

None

Table of Contents

Item 6. EXHIBITS AND REPORTS ON FORM 8-K

Certifications

Certifications Pursuant to the Sarbanes-Oxley Act

Reports on Form 8-K

None

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(b) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

UNITED STATES ANTIMONY CORPORATION

(Registrant)


By:	/s/ John C. Gustavsen	Date: November 15, 2021
John C. Gustavsen, Interim CEO (Principal Executive)

By:	/s/ Russell Lawrence	Date: November 15, 2021
Russell C. Lawrence, Interim President & Director